Peptides are everywhere, but do you actually know where they come from?

In this episode, we dig into the peptide supply chain and the difference between a product being sold, tested, filled, or packaged in the United States and the actual peptide API being manufactured here.

We break down why U.S. pharmaceutical companies rely heavily on foreign API manufacturing, the major countries behind peptide production, and why the country of origin doesn't necessarily determine quality.

We also take a closer look at BPC-157, what the research actually shows, what we still don't know about human safety and effectiveness, and why “research use only,” “99% purity,” and “Made in the USA” don't necessarily mean what consumers think they mean.

Finally, we tackle the bigger question: How much should FDA approval, or lack of approval, actu ...